Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals

Next Previous
X
Search
Trial Profile

A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Denosumab (Primary) ; Glucocorticoids; Risedronic acid
  • Indications Corticosteroid-induced osteoporosis
  • Focus Registrational; Therapeutic Use
  • Acronyms GIOP
  • Sponsors Amgen

    • Most Recent Events

    • 01 Jun 2022 Results assessing effects of denosumab compared with risedronate on bone strength and microarchitecture measured by high-resolution peripheral quantitative computed tomography glucocorticoid therapy (GC-I) or on long-term therapy, published in the Journal of Bone and Mineral Research.
    • 09 Nov 2021 Results of post hoc subgroup analysis (n=300) assessing safety and efficacy of denosumab versus risedronate in patients with glucocorticoid-induced osteoporosis and rheumatoid arthritis, presented at the ACR Convergence 2021.
    • 15 Jun 2019 Results (n=111) evaluating effect of Denosumab versus Risedronate on cortical and trabecular bone microarchitecture presented at the 20th Annual Congress of the European League Against Rheumatism

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top